Literature DB >> 23327370

Ebola virus outbreaks in Africa: past and present.

J J Muyembe-Tamfum1, S Mulangu, Justin Masumu, J M Kayembe, A Kemp, Janusz T Paweska.   

Abstract

Ebola haemorrhagic fever (EHF) is a zoonosis affecting both human and non-human primates (NHP). Outbreaks in Africa occur mainly in the Congo and Nile basins. The first outbreaks of EHF occurred nearly simultaneously in 1976 in the Democratic Republic of the Congo (DRC, former Zaire) and Sudan with very high case fatality rates of 88% and 53%, respectively. The two outbreaks were caused by two distinct species of Ebola virus named Zaire ebolavirus (ZEBOV) and Sudan ebolavirus (SEBOV). The source of transmission remains unknown. After a long period of silence (1980-1993), EHF outbreaks in Africa caused by the two species erupted with increased frequency and new species were discovered, namely Côte d'Ivoire ebolavirus (CIEBOV) in 1994 in the Ivory Coast and Bundibugyo ebolavirus (BEBOV) in 2007 in Uganda. The re-emergence of EHF outbreaks in Gabon and Republic of the Congo were concomitant with an increase in mortality amongst gorillas and chimpanzees infected with ZEBOV. The human outbreaks were related to multiple, unrelated index cases who had contact with dead gorillas or chimpanzees. However, in areas where NHP were rare or absent, as in Kikwit (DRC) in 1995, Mweka (DRC) in 2007, Gulu (Uganda) in 2000 and Yambio (Sudan) in 2004, the hunting and eating of fruit bats may have resulted in the primary transmission of Ebola virus to humans. Human-to-human transmission is associated with direct contact with body fluids or tissues from an infected subject or contaminated objects. Despite several, often heroic field studies, the epidemiology and ecology of Ebola virus, including identification of its natural reservoir hosts, remains a formidable challenge for public health and scientific communities.

Entities:  

Mesh:

Year:  2012        PMID: 23327370     DOI: 10.4102/ojvr.v79i2.451

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  46 in total

1.  Structural and molecular basis for Ebola virus neutralization by protective human antibodies.

Authors:  John Misasi; Morgan S A Gilman; Masaru Kanekiyo; Miao Gui; Alberto Cagigi; Sabue Mulangu; Davide Corti; Julie E Ledgerwood; Antonio Lanzavecchia; James Cunningham; Jean Jacques Muyembe-Tamfun; Ulrich Baxa; Barney S Graham; Ye Xiang; Nancy J Sullivan; Jason S McLellan
Journal:  Science       Date:  2016-02-25       Impact factor: 47.728

Review 2.  Climate change, health and infectious disease.

Authors:  Maya K Gislason
Journal:  Virulence       Date:  2015       Impact factor: 5.882

3.  Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.

Authors:  Frederick W Holtsberg; Sergey Shulenin; Hong Vu; Katie A Howell; Sonal J Patel; Bronwyn Gunn; Marcus Karim; Jonathan R Lai; Julia C Frei; Elisabeth K Nyakatura; Larry Zeitlin; Robin Douglas; Marnie L Fusco; Jeffrey W Froude; Erica Ollmann Saphire; Andrew S Herbert; Ariel S Wirchnianski; Calli M Lear-Rooney; Galit Alter; John M Dye; Pamela J Glass; Kelly L Warfield; M Javad Aman
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

4.  Ebola virus disease: history, epidemiology and outbreaks.

Authors:  Jacqueline Weyer; Antoinette Grobbelaar; Lucille Blumberg
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

5.  Suspected Exposure to Filoviruses Among People Contacting Wildlife in Southwestern Uganda.

Authors:  Tierra Smiley Evans; Leonard Tutaryebwa; Kirsten V Gilardi; Peter A Barry; Andrea Marzi; Meghan Eberhardt; Benard Ssebide; Michael R Cranfield; Obed Mugisha; Emmanuel Mugisha; Scott Kellermann; Jonna A K Mazet; Christine K Johnson
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

6.  Spatial Determinants of Ebola Virus Disease Risk for the West African Epidemic.

Authors:  Kate Zinszer; Kathryn Morrison; Aman Verma; John S Brownstein
Journal:  PLoS Curr       Date:  2017-03-31

Review 7.  Does the impact of biodiversity differ between emerging and endemic pathogens? The need to separate the concepts of hazard and risk.

Authors:  Parviez R Hosseini; James N Mills; Anne-Hélène Prieur-Richard; Vanessa O Ezenwa; Xavier Bailly; Annapaola Rizzoli; Gerardo Suzán; Marion Vittecoq; Gabriel E García-Peña; Peter Daszak; Jean-François Guégan; Benjamin Roche
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-06-05       Impact factor: 6.237

Review 8.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

9.  An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions.

Authors:  Dapeng Li; Tan Chen; Yang Hu; Yu Zhou; Qingwei Liu; Dongming Zhou; Xia Jin; Zhong Huang
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 10.  Cell Culture, Technology: Enhancing the Culture of Diagnosing Human Diseases.

Authors:  Shuaibu Abdullahi Hudu; Ahmed Subeh Alshrari; Ahmad Syahida; Zamberi Sekawi
Journal:  J Clin Diagn Res       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.